ArticleScientific reports2025
Evaluating the antimicrobial effect, compressive strength and fluoride release of glass ionomer cement modified with Triphala.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enhancement of the antibacterial properties of glass ionomer cement has gained substantial importance in contemporary restorative dentistry, as microbial biofilms are the primary cause of secondary caries and restoration failure. Recent advances focus on modifying glass ionomer cement by incorporating antimicrobial agents to significantly improve its antibacterial activity. Therefore, this study aims to evaluate the antimicrobial effect, compressive strength, and fluoride release of glass ionomer cement modified with Triphala. This in vitro study included a total of 78 glass ionomer specimens, which were allocated into three primary testing categories: antibacterial activity, compressive strength, and fluoride release. Specifically, (n = 24) specimens were designated for the antibacterial test, (n = 33) specimens for evaluating compressive strength, and (n = 21) specimens for assessing fluoride release. Each testing category was further subdivided into three groups based on the incorporation of Triphala into the glass ionomer cement. Group A served as the control, consisting of glass ionomer without Triphala, Group B included glass ionomer specimens modified with 1.25%wt Triphala, and Group C comprised glass ionomer specimens modified with 3%wt Triphala. There was a significant difference among the three groups in terms of antibacterial activity and fluoride release tests, with Group C exhibiting the highest values in both tests. However, no significant difference was reported between the mean compressive strength of the control group and the experimental groups. Results revealed that Triphala enhances the antibacterial and fluoride-releasing abilities without compromising the compressive strength of GIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.